Company Search:
Advanced Search
Sponsored Links
Bionime Corporation Company Snapshot
Bionime Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bionime with three other pharmaceutical manufacturers in Asia: Mizuho Medy Co Ltd of Japan (2016 sales of 4.96 billion Japanese Yen [US$44.01 million] ), Nissui Pharmaceutical Co., Ltd. of Japan (12.02 billion Japanese Yen [US$106.58 million] of which 43% was Clinical diagnostics business), and Kainos Laboratories, Inc. which is also based in Japan (5.35 billion Japanese Yen [US$47.42 million] ).

Sales Analysis. During the year ended December of 2016, sales at Bionime were 1.74 billion Taiwanese Dollars (US$57.00 million). This is an increase of 8.1% versus 2015, when the company's sales were 1.61 billion Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bionime Corporation
  Stock Performance Chart for Bionime Corporation
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 70.30
(Figures in Taiwanese Dollars)
1 Week 10.7%   13 Weeks 14.1%  
4 Weeks 27.1%   52 Weeks 33.4%  
Bionime Corporation Key Data:
  Ticker: 4737 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 1,740,309,000
(Year Ending Jan 2017).
Employees: 671
  Currency: Taiwanese Dollars Market Cap: 4,460,324,100
  Fiscal Yr Ends: December Shares Outstanding: 63,447,000
  Share Type: GU Closely Held Shares: 33,606,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.